These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 22011607)

  • 1. [Guideline: type 2 diabetes mellitus therapy: metformin, a critical perspective].
    Pinto D; Heleno B; Gallego R; Santos I; Santiago LM; Maria V
    Acta Med Port; 2011; 24(2):331-8. PubMed ID: 22011607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using metformin in the presence of renal disease.
    Chowdhury TA; Wright R; Yaqoob MM
    BMJ; 2015 Apr; 350():h1758. PubMed ID: 25873532
    [No Abstract]   [Full Text] [Related]  

  • 3. The FDA Revises Restrictions on Metformin Use in Kidney Impairment.
    Aschenbrenner DS
    Am J Nurs; 2016 Aug; 116(8):22-3. PubMed ID: 27466921
    [No Abstract]   [Full Text] [Related]  

  • 4. [Toxicity of metformin, pro- or con- a future restriction to its contraindications?].
    Wakim El Khoury J; Décosterd D
    Rev Med Suisse; 2013 Aug; 9(394):1473-7. PubMed ID: 24024392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. To: Holstein A, Stumvoll M (2005) Contraindications can damage your health--is metformin a case in point? Diabetologia 48:2454-2459.
    Ma RC; Chow CC; Tong PC; Chan JC; Cockram CS
    Diabetologia; 2006 May; 49(5):1127-8. PubMed ID: 16565848
    [No Abstract]   [Full Text] [Related]  

  • 6. Patients with Type 2 diabetes treated with metformin: prevalence of contraindications and their correlation with discontinuation.
    Rakovac I; Jeitler K; Gfrerer RJ; Habacher W; Seereiner S; Mrak P; Pieber TR;
    Diabet Med; 2005 May; 22(5):662-4. PubMed ID: 15842528
    [No Abstract]   [Full Text] [Related]  

  • 7. Contraindications can damage your health--is metformin a case in point?
    Holstein A; Stumvoll M
    Diabetologia; 2005 Dec; 48(12):2454-9. PubMed ID: 16283245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycemic Therapy for Type 2 Diabetes: Choices Expand, Data Lag Behind.
    Fradkin JE; Rodgers GP
    Ann Intern Med; 2017 Feb; 166(4):309-310. PubMed ID: 28055042
    [No Abstract]   [Full Text] [Related]  

  • 9. Metformin therapy in patients with type 2 diabetes complicated by heart failure.
    Inzucchi SE; Masoudi FA; McGuire DK
    Am Heart J; 2007 Dec; 154(6):e45. PubMed ID: 18035066
    [No Abstract]   [Full Text] [Related]  

  • 10. Metformin usage in type 2 diabetes mellitus: are safety guidelines adhered to?
    Huang W; Castelino RL; Peterson GM
    Intern Med J; 2014 Mar; 44(3):266-72. PubMed ID: 24405767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetes in the new General Medical Services contract: targets and adherence to metformin therapy.
    Kirby M
    Int J Clin Pract; 2005 Mar; 59(3):263-6. PubMed ID: 15857318
    [No Abstract]   [Full Text] [Related]  

  • 12. [Metformin and kidneys].
    Smahelová A
    Vnitr Lek; 2008 May; 54(5):535-40. PubMed ID: 18630642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inappropriate prescription for metformin.
    Cayley WE
    JAMA; 2002 Aug; 288(6):694; author reply 694-5. PubMed ID: 12169061
    [No Abstract]   [Full Text] [Related]  

  • 14. Metformin revisited: a critical review of the benefit-risk balance in at-risk patients with type 2 diabetes.
    Scheen AJ; Paquot N
    Diabetes Metab; 2013 May; 39(3):179-90. PubMed ID: 23528671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The practice guideline 'Diabetes mellitus type 2' (second revision) from the Dutch College of General Practitioners; a response from the perspective of general practice].
    Bouma M; Rutten GE; Wiersma T
    Ned Tijdschr Geneeskd; 2006 Oct; 150(42):2339-40. PubMed ID: 17091545
    [No Abstract]   [Full Text] [Related]  

  • 16. Metformin-associated lactic acidosis in type 2 diabetes mellitus: incidence and presentation in common clinical practice.
    Almirall J; Bricullé M; Gonzalez-Clemente JM
    Nephrol Dial Transplant; 2008 Jul; 23(7):2436-8. PubMed ID: 18388117
    [No Abstract]   [Full Text] [Related]  

  • 17. Levels of evidence needed for changing indications, contraindications, and Food and Drug Administration labeling: the case of metformin.
    Eurich DT; Majumdar SR; McAlister FA; Tsuyuki RT; Johnson JA
    Arch Intern Med; 2011 Jun; 171(11):1042-3; author reply 1043. PubMed ID: 21670379
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of guidelines on diabetes medication.
    Giaccari A; Giorda CB; Riccardi G; De Micheli A; Bruno G; Monge L; Frontoni S
    Ann Intern Med; 2012 May; 156(10):752-3; author reply 753. PubMed ID: 22586015
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluation of guidelines on diabetes medication.
    Brown K; Harbour R; Petrie J
    Ann Intern Med; 2012 May; 156(10):752; author reply 753. PubMed ID: 22586014
    [No Abstract]   [Full Text] [Related]  

  • 20. Metformin's contraindications should be contraindicated.
    McCormack J; Johns K; Tildesley H
    CMAJ; 2005 Aug; 173(5):502-4. PubMed ID: 16129871
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.